FH and myeloid sarcoma: The current study suggests that FH deficiency in MS-MSC contributes to adysfunctional bone marrow microenvironment in MS with potential significance formetabolic status and immunoregulation that warrants additional investigation todetermine whether this is a disease-specific effect with potential for therapeuticintervention.